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DOI 10.1186/s12864-015-1475-7RESEARCH ARTICLE Open AccessThe transcriptome of a complete episode of
acute otitis media
Michelle Hernandez1,5†, Anke Leichtle1,6†, Kwang Pak1,4, Nicholas J Webster2,4, Stephen I Wasserman3
and Allen F Ryan1,4*Abstract
Background: Otitis media is the most common disease of childhood, and represents an important health challenge to
the 10-15% of children who experience chronic/recurrent middle ear infections. The middle ear undergoes extensive
modifications during otitis media, potentially involving changes in the expression of many genes. Expression profiling
offers an opportunity to discover novel genes and pathways involved in this common childhood disease.
The middle ears of 320 WBxB6 F1 hybrid mice were inoculated with non-typeable Haemophilus influenzae (NTHi) or
PBS (sham control). Two independent samples were generated for each time point and condition, from initiation
of infection to resolution. RNA was profiled on Affymetrix mouse 430 2.0 whole-genome microarrays.
Results: Approximately 8% of the sampled transcripts defined the signature of acute NTHi-induced otitis media
across time. Hierarchical clustering of signal intensities revealed several temporal gene clusters. Network and pathway
enrichment analysis of these clusters identified sets of genes involved in activation of the innate immune response,
negative regulation of immune response, changes in epithelial and stromal cell markers, and the recruitment/function
of neutrophils and macrophages. We also identified key transcriptional regulators related to events in otitis media,
which likely determine the expression of these gene clusters. A list of otitis media susceptibility genes, derived from
genome-wide association and candidate gene studies, was significantly enriched during the early induction phase and
the middle re-modeling phase of otitis but not in the resolution phase. Our results further indicate that positive versus
negative regulation of inflammatory processes occur with highly similar kinetics during otitis media, underscoring the
importance of anti-inflammatory responses in controlling pathogenesis.
Conclusions: The results characterize the global gene response during otitis media and identify key signaling and
transcription factor networks that control the defense of the middle ear against infection. These networks deserve
further attention, as dysregulated immune defense and inflammatory responses may contribute to recurrent or chronic
otitis in children.
Keywords: DNA microarray, Otitis media, Mouse, Innate immunity, Inflammation, Negative regulators, Gene regulationBackground
Otitis media (OM) is the most prevalent disease of
childhood in developed countries, accounting for more
office visits and drug purchases than any other disease
from ages six months to six years [1,2]. Its cost in the
U.S. alone is estimated at more than five billion dollars
annually in office visits, pharmaceutical agents, surgery* Correspondence: afryan@ucsd.edu
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unless otherwise stated.and lost productivity [2,3]. Antibiotics provide a gener-
ally effective therapy for acute OM (AOM). Since their
widespread availability, OM rarely results in a life-
threatening disease, as it once did for the proportion of
patients who progressed to meningitis. However, in the
developing world, OM remains a serious threat to
health. The World Health Organization estimates that
approximately 30,000 annual deaths can be attributed to
OM, and further estimates that half of the world’s
burden of permanent, serious hearing loss (>175 million
individuals) involves OM [4].
Even in the developed world, there remains a high
degree of morbidity associated with both active infectiontral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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impacts are controversial, numerous reports link hearing
loss due to persistent OM to deficits in speech perception
[5], delayed language acquisition [6] and learning disabil-
ities [7]. Given the cost and potential sequelae of OM,
there is a clear need for a better understanding of its
pathogenesis in order to develop more effective therapies.
Because the middle ear (ME) mucosa undergoes ex-
tensive modification during OM, including the recruit-
ment of nonresident leukocyte species, there is potential
for changes in the expression of many genes. The mo-
lecular response that occurs in the ME during OM is
complex, and provides many opportunities for differ-
ences in OM phenotypes among individuals who may
express different forms of critical proteins or may have
mutations in critical genes. For instance, polymorphisms
in several components of the immune system, such as
Toll-like receptor 4 (TLR4) [8], Mannose Binding Lectin
[9], and pro-inflammatory cytokines such as TNF-alpha
(tumor necrosis factor) and Interleukin-1 (IL-1) [10],
have been reported to be associated with OM suscepti-
bility, as well as polymorphisms in other genes that im-
pair proper healing after a previous episode of OM [8].
In addition, mouse mutants that exhibit chronic OM
have been reported. Mutations in the Fbxo11 [11] or
Evi1 [12] genes result in chronic OM, perhaps through
changes in the development of the ME [11,13].
The role of the mucosa as an important regulator of
the immune response has been studied in various dis-
ease and therapeutic contexts. A theory regarding the
pathogenesis of inflammatory bowel disease is that the
intestinal epithelium cannot adequately balance pro- and
anti-inflammatory signals in response to enteric bacteria
[14]. Mucosal immunity is also being assessed in thera-
peutics, such as in the development of the intranasal
influenzae vaccine [15] and sublingual allergen immuno-
therapy [16]. The study of the ME mucosa throughout a
course of OM may provide insights into the factors that
predispose certain individuals to develop its more chronic
forms, such as recurrent/chronic OM or OM with effusion.
As so many genes are potentially involved during OM,
there is a need to use technologies that can evaluate a
large number of gene expression profiles simultaneously
in a specific tissue of interest. DNA microarrays offer a
broad strategy by which to discover novel genes involved
in OM, and to clarify the participation of known genes
within complex signaling networks. Previous studies
using gene arrays have been performed [17,18] and have
yielded valuable information. However, they differed from
the current study in several important aspects. These
include the use of arrays with limited numbers of genes,
characterizing one or two time points after the induction
of infection, using heat-killed bacteria, or omitting a con-
trol for injection trauma. The present study evaluates thecomplete kinetics of the ME response to AOM, from
initiation of infection to resolution after inoculation
with non-typeable Haemophilus influenzae (NTHi), one
of the most common human pathogens isolated from the
ME in OM. Infection with this gram-negative organism
characteristically leads to hyperplasia of the ME mucosa
and leukocyte infiltration in the ME cavity [19,20]. Ana-
lysis of this transcriptome data set highlights the genes
that are involved in the acute induction of OM as well as
tissue remodeling, bacterial clearance and resolution. It
also identifies key pathways that participate in the ME
response as well as the interplay between pro- and anti-
inflammatory processes that occur in the ME mucosa as
it reacts to infection.
Methods
Animals
All experiments were performed on naïve, young adult
(60–90 days old) WBxB6 F1 hybrid mice (Jackson Labs)
during daylight hours, according to National Institutes
of Health guidelines on the care and use of laboratory
animals and were approved by the Institutional Animal
Care and Use Committee of the San Diego VA Medical
Center, San Diego, CA. All experiments were conducted
in accordance with NIH/PHS policies on the Humane
Care and Use of Laboratory Animals. Mice were healthy
and were housed under normal SPF conditions in standard
rodent boxes with enrichment and free access to food and
water. All animals remained healthy during the study.
Acute OM in wildtype mice is very similar to that observed
in humans [21], but the use of animals allows documenta-
tion of the complete course of disease, while the genetic
resources available for the mouse are extensive.
Bacterial strains and culture conditions
Haemophilus influenzae strain 3655 (non-typeable, bio-
type II; NTHi) was used at a concentration of 105 – 106/
ml to induce an inflammatory response in the ME. The
inocula were prepared as described in Melhus and Ryan,
2003 [21]. Strain 3655 was originally isolated from the
ME of child in St. Louis, MO. It is often associated with
respiratory tract infections, including otitis media [22]. It
was used because we have extensive experience with this
strain.
Surgical procedure
WBxB6 F1 hybrid mice were inoculated bilaterally in the
ME with NTHi in a laboratory setting under aseptic
conditions. An identical number of control mice were
injected with saline. The mice were anesthetized with an
intraperitoneal injection of 0.1-0.2 ml per 25–30 g body-
weight of rodent cocktail (13.3 mg/ml Ketamine HCl,
1.3 mg/ml Xylasine and 0.25 mg/ml Acepromazine),
which produces deep anesthesia for the required period.
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proach through a vertical midline incision on the neck. To
access the ME cavity, the bulla was fenestrated using a 25
gauge syringe needle. Approximately 3–5 μl of NTHi (105-
106 NTHi/ml) or endotoxin-free PBS (sham) was injected
into the ME cavity of mice and rats. Excess fluid was
absorbed with a sterile cotton swab. The wound was closed
by replacing the tissue and the skin incision was stapled.
After surgery, the animals received a subcutaneous injec-
tion of buprenorphine and lactated Ringer’s injection.
Histology
Mice used for histology (3 per time point) were sacri-
ficed under general anesthesia by intracardiac perfusion
with PBS followed by 4% Paraformaldehyde (PFA) at
0 hours (0 h, no inoculation), 6 h, 12 h, and 1, 2, 3, 5,
10, 14, and 21 days (21d) after inoculation. For each bac-
terial preparation, animals from all time points were in-
cluded. The six MEs were dissected, post fixed (4% PFA)
overnight and decalcified (8% EDTA and 4% PFA) for
14d. The decalcified ME bullae of mice were embedded
in paraffin and sections were cut at 7 μm. The sections
were stained with hematoxylin and eosin (Figure 1). Sec-
tions from the same region of each ME, in the largest
part of the ME cavity, were digitally recorded and muco-
sal thickness as well as the percent area of the ME
lumen occupied by inflammatory cells were determined
at standard locations as described elsewhere [23].
Inflammatory cell recruitment
The number of neutrophils and macrophages compris-
ing ME cellular infiltrates was assessed by two independ-
ent observers, by manually counting these cell types in
five randomly selected clusters of cellular ME effusions
for each ME in a 400x high power field. The numbers
were then computer-averaged.
DNA microarray
For each array sample, ME mucosae from 20 mice were
harvested at each of the following time points after in-
oculation with either NTHi or PBS: 3 h, 6 h, 24 h (1d),
48 h (2d), 72 h (3d), 120 h (5d), and 168 h (7d). For each
bacterial preparation, two groups from widely separated
time points were performed (more than two groups
could not be performed in a day). Mice were sacrificed,
after deep anesthesia as above, by decapitation. Each
inoculation time was repeated twice and duplicate, in-
dependent samples generated. The tissue was homoge-
nized in TRIzol™ reagent (Invitrogen) and total RNA
extracted. Five micrograms of mRNA per treatment
per sample were analyzed on two Affymetrix mouse
MU430 2.0 gene chips per time point by the Micro-
array Core at the San Diego Veterans Medical Research
Foundation.Data were analyzed using multiple, independent strat-
egies by an individual blinded to the OM phenotype of
each sample. Principal component analysis was performed
on the arrays for quality control using RMA (robust multi-
array average) normalization [24] in Partek Genomic Solu-
tions (Figure 2A). To identify changes in gene expression,
the data were first analyzed using a variance modeling ap-
proach. The raw MAS5 expression values were imported
into VAMPIRE without prior normalization. This program
uses a Bayesian approach to identify altered genes [25].
Statistical analysis by VAMPIRE requires two distinct
steps: (1) modeling of the error structure of sample groups
and (2) significance testing with a priori-defined signifi-
cance thresholds. VAMPIRE models the existing error
structure to distinguish signals from noise and identify the
coefficients of expression-dependent and expression-
independent variance. These models are then used to iden-
tify microarray features that are differentially-expressed
between treatment groups. Mice inoculated with NTHi
were compared to mice injected with saline at each time
point to generate sets of genes that change due to NTHi
infection and to eliminate gene changes due to the trauma
of the injection. Bonferroni multiple testing correction
(MTC, αBonf < 0.05) was applied to identify only those
genes with the most robust changes. The genes altered at
each time were combined to give a set of genes differen-
tially regulated between NTHi and PBS. The analysis in
VAMPIRE was then repeated using data that had been
prior normalized using CORGON [26] and the two data-
sets compared.
Thirdly, the time course data were analyzed using a
curve-fitting algorithm implemented in EDGE. Instead
of using a standard statistical comparison of two condi-
tions, one gene at a time, this program implements the
Optimal Discovery Procedure to take into account
dependent information in the data [27]. This is particu-
larly useful for time course data. The program fits a nat-
ural cubic spline to the time course data and then tests
whether the fit to the actual data is significantly better
than to the data averaged between conditions or to an
invariant gene. The time courses following NTHi or PBS
inoculation were compared to each other to generate
sets of genes whose time course differed significantly be-
tween treatments. MTC was applied by false discovery
rate (FDR, q < 0.05). Lastly, the data were analyzed by 2-
way ANOVA in GeneSpring Ver 12.6 (Agilent, CA)
using time and treatment as the two variables. Again,
FDR correction was applied to the data. The genes sig-
nificant for treatment or time treatment were combined
to generate a list of NTHi-regulated genes.
The overlap of the four gene sets was compared by
Venn diagram for NTHi-regulated genes (Figure 2B).
The final list of NTHi-regulated genes was created by
combining genes that were positive by >2 statistical
Figure 1 Otitis Media time course with NTHi. A. Baseline (0 h) B. 6 h C. 24 h D. 48 h E. 72 h F. 168 h. The MEs of WBxB6 F1 hybrid mice
undergo mucosal hyperplasia with infiltration of inflammatory cells, with a peak of inflammatory changes at 48 hours. The ear resembles its
baseline appearance by 168 h (7d). G. Neutrophils are evident in the ME cavity by 6 h after inoculation H. Macrophages, much less numerous
overall than neutrophils, are most prominent at 48 h. I. Quantification of neutrophil and macrophage numbers in the ME cavity after
NTHi inoculation.
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ANOVA).
This final set of 3657 NTHi-regulated transcripts
(Additional file 1: Table S1) was imported into Gene-
Spring for visualization. The final gene set was subjected
to hierarchical clustering using Euclidean distance mea-
surements (Figure 2C). Inspection of the resultingheatmap showed a number of gene clusters with similar
expression profiles. The expression profiles of these clus-
ters were generated based on the median-normalized
MAS5 data (Figure 2D and Additional file 2: Figure S1).
Lists of genes altered at each time point and treatment
generated by VAMPIRE were mapped to gene ontology
terms using the program GOby to determine whether
Figure 2 Transcript signature of AOM with NTHi. A. Principal component analysis of sample variation. Colors of symbols indicate different
times and shapes of symbols indicate different treatments. B. 4-way Venn diagram with number of genes differentially expressed with NTHi versus
saline treatment as analyzed by four statistical methods. C. Heat map for 3657 significant genes identified by the combined statistical analysis,
comparing time course of saline treatment to NTHi treatment. The final set of altered genes was defined by combining genes that were significant by
2 statistical methods: variance modeling (raw or normalized data), curve fitting, or 2-way ANOVA). D. Expression profiles of four clusters of up-regulated
transcripts, showing induction at different times after NTHi inoculation.
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(αBonf < 0.05) was applied to minimize GO terms arising
as false positives. Lists of genes in each cluster were
mapped to manually curated pathways and processes
using MetaCore (GeneGo, St. Joseph, MI). Network ana-
lysis was performed on the sets of cluster genes to iden-
tify transcription factors (TFs) underlying transcriptional
regulation of those genes. TF networks were rankedbased on p-values and z-scores in MetaCore. The data
were also analyzed for gene set enrichment using gene
set enrichment analysis (GSEA) [28]. This approach does
not rely on a prior statistical analysis but uses the ranked
order of all gene transcripts sampled to look for enrich-
ment in one condition versus another, regardless of
whether the expression difference was significant or not.
Enrichment of all curated or KEGG pathways (C2) or
Hernandez et al. BMC Genomics  (2015) 16:259 Page 6 of 16immunological signature gene sets (C7) in NTHi versus
saline was calculated for each time point.
The GSEA was also performed with custom gene sets
for epithelial cells and hemaotopoietic cell markers. To
assess changes in the epithelium, a new group of gene
sets was created by combining all existing gene sets
derived from studies of epithelial cells. To assess re-
cruitment of leukocytes and lymphocytes, a published
expression dataset on purified human immune cells
[29] was reanalyzed in GeneSpring. Two approaches
were used to identify cell specific markers for different
populations. Initially, the 50–100 most highly
expressed genes in each cell-type were selected, then
any of these genes that had appreciable expression in
other cells were serially subtracted until the final set of
selected genes was obtained that had at least 10-fold
higher expression in the cell-type of interest. Secondly,
a synthetic gene with the desired expression profile
was created with high expression in the desired cell
and low expression elsewhere, then genes were ana-
lyzed for correlation to the synthetic profile. Genes
with a correlation coefficient >0.9 were selected. The
two lists of cell-enriched genes were combined to give
a gene set of cell-type markers. The gene IDs were
then translated into mouse genes and the gene set used
in a GSEA with the NTHi dataset.
We also created a geneset containing genes that have
been associated with OM. This consisted of genes de-
rived from GWAS studies, which were downloaded from
the NHGRI website, and a number of candidate genes
that have been observed or tested in animal models of
OM [30-33].
Results
ME responses in AOM
All animals remained healthy throughout the period of
the study. Figure 1 illustrates the typical changes seen
during a time course of AOM after inoculation with
NTHi. The normal tympanic cavity is a relatively quies-
cent tissue environment in which the ME mucosa and
Eustachian tube serve two primary functions: they main-
tain the gaseous and pressure environment of the ME
and maintain a first line of defense against potential in-
fection. Consistent with this role, the ME mucosa of un-
treated mice consisted of a simple, squamous epithelial
monolayer with a minimal stroma. In response to NTHi,
the mucosa underwent substantial hyperplasia, convert-
ing to a pseudostratified, respiratory epithelium with
multiple cell layers and a greatly expanded stroma and
vasculature. The hyperplasia peaked at 2-3d after inocu-
lation. This hyperplasia was accompanied by an infiltra-
tion of inflammatory cells into the ME cavity as early as
6 h after infection (Figure 1B). Neutrophil numbers
peaked in the ME cavity at 24 h after NTHi inoculation,whereas macrophage numbers peaked 48-72 h after in-
oculation (Figure 1I). While most MEs were culture
positive at 1, 2 and 3d post-inoculation, clearance of
NTHi was complete by 5d (data not shown). Recovery
from OM was characterized by rapid loss of additional
cells from the ME mucosa and the ME cavity (Figure 1E-1F),
and a return to a relatively simple epithelial morphology by
5-7d after NTHi inoculation.
Analysis of the AOM transcript signature with NTHi
ME mucosal samples derived from mice inoculated with
NTHi were subjected to whole-genome-wide transcript
expression profile analysis using oligonucleotide-based
DNA microarrays. Principal component analysis of the
variance showed that arrays clustered primarily by time
with no outliers (Figure 2A). The third principal compo-
nent of the variance showed separation of the samples
by treatment (Additional file 2: Figure S1A). The early
time points clustered together as did the late times, with
the 5 and 7d time points looking similar to the untreated
mice. The greatest variation was seen at 24 h when neu-
trophil invasion is maximal. Of the 45,000 transcripts
represented on these microarrays, 3,657 transcripts were
differentially expressed with NTHi inoculation com-
pared to saline injection (Figure 2B, Additional file 1:
Table S1). Thus, approximately 8% of the transcripts de-
fines the signature of NTHi-induced AOM in the
mouse. Hierarchical clustering of the signal intensities of
the individual transcripts showed a number of distinct
expression patterns (Figure 2C). Specifically, four clus-
ters of up-regulated gene expression profiles were noted
(Figure 2D) and three clusters of down-regulated gene
expression profiles were noted (Additional file 2: Figure
S1B-D).
The early induction phase
Cluster A (Figure 2D) represents the earliest wave of
gene expression, peaking 3-6 h after NTHi inoculation
with expression extinguished by 24-48 h suggesting that
these genes initiate the response to NTHi. This cluster
of 259 genes includes Il6, Il22, Ccl20 (MIP3A), Ccl17,
Ccl19, Cxcl1 (GRO-1/KC), Csf2 (GM-CSF), Csf3 (G-
CSF) (Figure 3A), the growth factor genes Hbegf, Ereg
and Areg (Figure 3B), and the TNF-induced genes
Tnfaip-2, −3, and −6. GO, pathway and process analysis
showed that these genes represent ontology groups and
pathways related to immune and defense response, and
the response to biotic stimulus and LPS, interleukin,
TLR and TNFR signaling, and NFκB and neutrophil ac-
tivation (Additional file 3: Table S2). CXCL1 is a neutro-
phil chemoattractant and CSF3 promotes neutrophil
survival, proliferation and differentiation, which likely
contribute to the appearance of infiltrating neutrophils
starting at 6 h [19]. Analysis of transcription factor
Figure 3 Gene expression of selected genes. A-L. Expression profiles of selected sets of genes over time after NTHi inoculation plotted as log
2-fold change vs. time 0 (no injection). A. Cytokine genes. B. EGF family member genes. C. Chemokine, anti-bacterial and anti-viral genes. D.
Genes involved in cAMP signaling. E. Phagocytosis genes. F. Neutrophil and neutrophil oxidase markers. G. Alternative complement genes. H.
Mucin genes. I. Stromal genes. J. Macrophage genes. K. Antibacterial and cytokine genes that are elevated during the resolution phase. L.
Lymphocyte and leukocyte markers.
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connected factor followed by SP1, C/EBPβ, and the AP-
1 subunits c-Fos and c-Jun (Additional file 3: Table S2).
The largest transcription factor network generated from
this cluster contained 105 genes and was focused on
NFκB but included CREB1 and C/EBPβ (Figure 4, Additional
file 3: Table S2). This may be related to the observation that
TLRs can signal via cAMP and JNK in addition to the more
well-known NFκB pathway [34]. When signaling pathways
were included in the network analysis, the network nowFigure 4 Dominant TF network analysis of the cluster of genes up-reg
CREB1 networks are most highly represented in the cluster. The lines repre
interaction between the genes in question. All of the genes in the diagram
CREB1, GATA3, FOXP3, ESR1, p300, AKT (PKB) and c-Src.included HB-EGF and EREG-mediated EGFR signaling
through C/EBPβ, c-Src and AP-1.
Similar enrichment results were found using gene set
enrichment analysis of KEGG pathways at 3 and 6 h
(Additional file 4: Table S3). GSEA also indicated that 18
of the top 20 enriched pathways at 3-6 h are involved in
TLR, cytokine, chemokine and innate immune signaling.
The other enriched pathways were JAK/STAT signaling
and cell death/apoptosis. Looking specifically at epithe-
lial responses, the NTHi inoculated samples were highlyulated at 3 and 6 hours after NTHi inoculation. The NFκB and
sent a known stimulatory (green), inhibitory (red) or undefined (grey)
were up-regulated, with the exception of Oct3/4, TCF7L1, TFIID,
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pylori and the epithelial to mesenchymal transition
(EMT) suggesting that breakdown of the epithelial layer
and loss of differentiated phenotype is an early event in
AOM. This is supported by the observation that Zeb1
expression, a marker of EMT [35], is increased at 3-6 h
as is the growth factor gene Hbegf which promotes EMT
in several cell types e.g. [36,37]. We have recently shown
that HB-EGF is a potent stimulant of ME mucosal
growth in vitro [38]. GSEA for transcription factor tar-
gets at the 3 h time point indicated that the top 5 gene
sets comprised NFκB targets. At 6 h, NFκB targets still
scored highly but IRF/IRF2 targets were also in the top 5
enriched sets consistent with induction of interferon ex-
pression and signaling at these early times.
The second cluster (Figure 2D, Cluster B) contains 53
genes and is characterized by an early peak of expression
at 6 h, then a second peak at 48 h. This cluster is
enriched for STAT1/2 and IRF1/7/8 targets and the
enriched pathways include interferon and JAK/STAT sig-
naling, anti-viral responses, the inflammasome and
leukocyte chemotaxis. Interestingly, the Stat1 and Stat2
genes themselves show this pattern of expression. The
chemokine genes Cxcl10 (IP-10), and Cxcl11 (I-TAC)
are present in this cluster as are the antimicrobial pep-
tide gene Hamp, and the anti-viral genes Oasl1, Oasl2,
Ifit1, Ifit2, and Ifit3 (Figure 3C). These latter genes are
expressed by macrophages, so we interpret the biphasic
expression to indicate that the early expression is from
the epithelial and/or dendritic cells and the later expres-
sion due to the infiltrating macrophages that appear
48 h after inoculation.
Four hundred and forty-one genes are down-regulated
during this early phase at 6 h after inoculation. Pathway
and process enrichment showed that genes involved in
ATP metabolism and WNT signaling were altered. Many
of these genes were targets for CREB1 and c-MYC The
ability of cAMP to repress genes may be related to the
observation that Pde4b, Atf3, and Crem1 are induced
during this early phase (Figure 3D) to repress CREB ac-
tivity. GSEA indicates genes involved in fatty acid oxida-
tion and mitochondrial oxidative phosphorylation and
protein translation are enriched in the down-regulated
genes. Fatty acid oxidation has long been known to be
down-regulated by endotoxins in other tissues e.g. [39].
This is consistent with the switch from differentiated
oxidative epithelial cells to proliferative glycolytic mes-
enchymal cells.
The bacteriocidal phase
A large cluster of 510 genes (Figure 2D, Cluster C)
showed peak gene expression 24 h after NTHi inocula-
tion. These genes represent ontology groups and path-
ways including immune and inflammatory response,chemotaxis, phagocytosis, neutrophil activation, im-
munological synapse formation, alternative complement
activation, cytotoxicity, and ROS production. GSEA at
24 h indicated that genes involved in infection, TLR,
chemokine and cytokine signaling are enriched as before,
but genes involved in phagocytosis are also enriched, in-
cluding Vav1, Sirpa, Cdc42se1, Cdc42ep2, Fcgr2b/3, and
Coro1a (Figure 3E). This cluster also contains markers for
neutrophils (Csf3r, Fpr2, Cd177, Orm1, Orm2) and for the
neutrophil NADPH oxidase subunits Ncf1, Ncf2 and Ncf4
that mediate superoxide burst production (Figure 3F).
This coincides with the maximal infiltration of neutrophils
that is seen histologically. Also elevated are the genes
S110a8 and S100a9 that facilitate NADPH oxidase com-
plex formation and activation, and that are prominently
expressed in neutrophils. Genes involved in alternative ac-
tivation of the complement pathway (C5ar1, C2, Cfp, C3,
C1qbp, and Lman1) (Figure 3G) and mucin production
(Muc5ac, Muc5b, Muc13, and Muc16) are also induced
(Figure 3H), indicating ongoing bacteriocidal activity.
Stromal genes such as Bst1/2 and Epsti1 are elevated con-
sistent with the proliferation of stromal cells (Figure 3I).
Interactome connectivity analysis of the transcription fac-
tors driving this expression pattern showed that PU.1 was
the most over-connected (Additional file 3: Table S2;
Additional file 5: Figure S2), along with SP1 and
STAT3. The largest transcription factor networks, how-
ever, were derived from CREB, SP1, and c-MYC indi-
cating that quantitatively these TFs have more targets,
but that their targets are not as enriched as those for
PU.1 (Additional file 3: Table S2).
There is also a cluster of 358 genes that are down-
regulated 24 h after NTHi inoculation (Additional file 2:
Figure S1, Cluster F). These genes represent ontology
groups related to microtubule-based movement, ciliary
morphogenesis, and cell projection organization consist-
ent with de-differentiation and possibly the loss of cili-
ated epithelial cells. We have previously reported that
induced expression of one of these genes, Ecrg4, de-
creases the growth of infected ME mucosa, and reduces
leukocyte infiltration of the ME during OM [40]. GSEA
showed enrichment of genes involved in fatty acid and
amino acid metabolism and oxidative phosphorylation
similar to the genes down-regulated at 6 h, but also
showed decreases in drug and xenobiotic metabolism,
extracellular matrix interaction, tight junction formation,
and hedgehog and TGFβ signaling in agreement with
the progressive epithelial-to-mesenchymal transformation.
A subsequent peak of gene expression occurs at 48-
72 h (Figure 2D, Cluster D). This cluster contains 164
genes and consisted of genes involved in the alternative
complement pathway, CCL2 signaling, chemotaxis,
phagocytosis that are significantly up-regulated at this
relatively late stage. This cluster included macrophage
Hernandez et al. BMC Genomics  (2015) 16:259 Page 10 of 16specific markers such as Marco, Msr1, Mpeg1, and
Cd84, indicating the infiltration of macrophages at this
time point (Figure 3J). These responses are consistent
with tissue remodeling and the initial stages of cognate
immunity. The most significant TF was the macrophage
specific factor PU.1. A cluster of 98 genes showed re-
pressed expression between 24-48 h. Within this gene
set, transcripts representing morphogenesis and develop-
ment predominated.
The resolution phase
By 5 to 7d after NTHi inoculation, the ME mucosa has
remodeled mostly back to baseline, and the inflamma-
tory cell infiltrate has disappeared. While most genes
had returned to pre-inoculation levels, 164 genes
remained significantly up-regulated 7d after NTHi in-
oculation. Amongst these transcripts, the orosomucoid
genes Orm1/2 (Figure 3F), serum amyloid genes Saa1/2/3,
and the S100a8/9 genes (Figure 3K) exhibited continued
expression compared to saline, suggesting ongoing anti-
bacterial surveillance. Markers such as Msr1, CD177,
Cd84, Ccl9 and CXCL5/9/17 are still elevated indicating
the continued presence of leukocytes and, interestingly,
lymphocyte marker genes such as CD3, Pigr, Igh, and Tcrg
are observed, indicating the induction of cognate immunity
(Figure 3L). In contrast, genes encoding innate immune re-
ceptors and signaling molecules were not represented, con-
sistent with a lack of any type of “memory” that could be
associated with enhanced long-term expression of genes in
the innate immune system.
Participation of cell types during AOM with NTHi
Additional analytical tools were used to track the ap-
pearance of specific leukocytes during the course of
AOM. In particular, GSEA was applied using gene sets
derived from human hematopoetic cell profiling and
other immunological signature data sets. This analysis
provided an analysis of cell infiltration between NTHi
versus saline injection by the simultaneous analyzing of
numerous sets of genes typically expressed in leukocyte
subsets not just known cellular marker genes. After 3-
6 h of inoculation, the top 20 enriched gene sets are all
derived from LPS-stimulated monocytes, macrophages
or DCs (Additional file 4: Table S3). Since macrophages
are typically not observed in the ME at this time [19],
this suggests the presence and response of dendritic cells
which can be difficult to identify in H & E sections. At
24 h, thirteen of the top 20 gene sets are monocyte de-
rived, but gene sets from T-cells, neutrophils and eosin-
ophils are also enriched. This confirms the data above
regarding neutrophil-specific markers. While we do not
see eosinophil and T-cell markers in our cluster analysis,
this may reflect that the genes did not reach significance
due to the multiple testing correction, or they did notappear in any particular cluster. Monocyte gene sets are
again predominant at 48-72 h in agreement with the ap-
pearance of macrophage specific markers, but gene sets
derived from the response to viral infections or vaccine
treatment are also enriched. At later times, the top
enriched gene sets are derived from vaccine-stimulated,
virally-infected and lupus derived peripheral blood
mononuclear cells and T-cell derived gene sets. These
enriched T-cell gene sets indicate that lymphocytes in-
volved in the adaptive immune response remain in the
ME mucosa after resolution of the acute infection, how-
ever the presence of these lymphocytes is not easily ob-
served by routine H & E staining of the ME.
Both pro- and anti-inflammatory cytokine and cytokine
signaling genes are up-regulated rapidly in response to
NTHi
As pro-inflammatory cytokine signaling ontology groups
are represented both at the early induction and middle
bacteriocidal stages of AOM, we evaluated the expression
profile of cytokine signaling genes during NTHi infection.
Figure 3A shows that NTHi up-regulates expression of
IL-6 by approximately 500-fold at 3-6 h after inoculation.
The IL-6 peak declines, followed by significant increases
in other general pro-inflammatory cytokines such as IL-1
beta (60X) and TNF-alpha (130X) peaking at 24 h after
NTHi inoculation. Pro-inflammatory cytokine expression
was accompanied by up-regulation in anti-inflammatory
cytokines such as IL-1 receptor antagonist (130X), which
competes for binding to the IL-1 receptor, and IL-10 (9X
at 3-6 h) (Additional file 5: Figure S2).
Regulation of genes in the downstream JAK/STAT
pathway was visualized on a pathway diagram, in which
expression relative to pre-inoculation levels were color-
coded across time (Figure 5). In general, both pro- and
anti-inflammatory elements within the network were ac-
tivated with very similar kinetics, characterized by early
up-regulation. An exception was CAV1, a direct negative
regulator of STATs, which was down-regulated early,
then up-regulated later in OM.
Innate immune signaling genes are up-regulated in AOM
with NTHi
The kinetics of the pro-inflammatory cytokine profile
seen in the NTHi-treated groups suggested that signal-
ing through TLRs was important in initiating the inflam-
matory response in AOM. These changes are visualized
on the TLR/IL1 signaling pathway diagram as for the
JAK/STAT pathway before (Figure 6). Although none of
the TLRs was up-regulated significantly with sham
inoculation, several were up-regulated with NTHi
(Additional file 5: Figure S2). TLR2 was strongly in-
duced in the NTHi treated group, with significant in-
creases occurring 3 h after inoculation and peaking
Figure 5 Regulation of genes in the JAK/STAT signaling pathway. Diagrammatic representation of responses for genes involved in JAK/STAT
signaling. For each gene, expression has been represented relative to 0 h across the course of AOM, from 3 h to 7d; with white representing no
change, red: up-regulation and green: down-regulation. The degree of regulation is indicated by color intensity. Both proinflammatory and
anti-inflammatory signaling genes are regulated with similar kinetics. An exception is the STAT inhibitor CAV1, which is down-regulated early
in AOM.
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groups compared to sham at 24 h after NTHi inocula-
tion, though the function of this murine-specific TLR
has not been defined to date. While TLR4 was not sig-
nificantly up-regulated, expression of the TLR4 co-
receptor CD14 was strongly enhanced by NTHi (11X at
24 h). NOD-like receptor (NLR) family members were
also significant after Bonferroni correction. NLRP3, also
known as NALP3 and CIAS, is a member of the
caspase-1 inflammasome leading to pro-IL-1 beta and
pro-IL-18 processing. NLRP3 was modestly but signifi-
cantly up-regulated (3-4X) at 6 and 24 h after NTHi
treatment compared to sham. Another element of the
inflammasome, ASC (also known as PyCard) was sig-
nificantly up-regulated (3X) 24 h after NTHi inocula-
tion. We have recently shown that mice deficient in
ASC exhibit dramatically reduced IL-1 beta processing
and delayed bacterial clearance from the ME during
OM [41].
Positive and negative regulators of innate immune
signaling are up-regulated by NTHi with similar kinetics
The pro-inflammatory burst noted above is also accom-
panied by induction of negative regulators of TLR- andNOD-associated intracellular signaling that serve to
dampen the induction of cytokine production. As illus-
trated in Figure 6, IRAK3, a negative regulator of TLR
signaling which prevents the dissociation of IRAK-1 and
IRAK-4 from MyD88 [42], was induced 6 h after NTHi
inoculation, peaking 24 h (35X) after inoculation and
remaining elevated through 120 h. Similarly, we see in-
duction of inhibitor of kappa-B kinase Ikbke and nuclear
factor of kappa light polypeptide gene enhancer in B cell
inhibitors Nfkbia/b/d/e that dampen NFκB signaling.
Suppressor of cytokine signaling 1 (SOCS1, 10-15X 3-
24 h) and SOCS3 (5X, 3-6 h) were also evaluated.
NLRP12, a negative regulator of TLR signaling via in-
hibition of NFκB activation by either canonical or
non-canonical signal transduction pathways [43], was
significantly up-regulated compared to sham treat-
ment at 3 and 24 h after NTHi treatment (5-14X).Discussion
As a survey tool, DNA microarray analysis can provide
simultaneous data on the expression of essentially all
mouse genes during AOM. Using this approach, our re-
sults identify discreet waves of genes that are activated
Figure 6 Regulation of genes in IL1/TLR signaling pathways. Diagrammatic representation of responses for genes involved in IL-1 and TLR
signaling during NTHi-induced AOM. Gene regulation indicated as in Figure 5. Pro-inflammatory genes within the direct signaling pathway and
anti-inflammatory regulatory genes are expressed with similar kinetics.
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by NTHi.
Using various systems biology approaches to integrate
expression profiling with histological data, we provide a
model of the changes occurring during an episode of
AOM (Figure 7). The earliest gene regulation events in-
volved activation of the innate immune and interleukin
signaling networks, within hours after the mucosal epi-
thelial cells sensed danger signals in the ME cavity. TLR
activation leads to induction of NFκB and CREB target
genes and the inflammatory response is initiated.
Growth factors, cytokines and chemokines orchestrate
the anti-microbial response and mucosal remodeling.
The epithelium undergoes transition to a mesenchymal
phenotype triggered by HB-EGF, and transitions from
differentiated, oxidative cells to proliferative glycolytic
cells allowing mucosal expansion. Neutrophils are
attracted by CXCL1 and other chemoattractants pro-
duced by the epithelial cells and CSF3 promotes neutro-
phil survival, proliferation and differentiation which
likely contribute to the histological appearance of infil-
trating neutrophils starting at 6 h. Neutrophil markers
are maximally induced at 24 h, that coincides with the
maximum number of neutrophils by histology. Expres-
sion of NADPH oxidase subunits is maximal, mucins are
produced and the alternative complement pathway is ac-
tivated creating a bacteriocidal environment. Macro-
phages are attracted by CCL2, CCL3, CCL4 and otherchemokines that are produced maximally at 24 h and
macrophage markers appear at 24-72 h. Genes involved
in phagocytosis are elevated between 24 and 72 h as leu-
kocytes clear killed bacteria. Finally, genes related to tis-
sue remodeling predominate at 5-7d post inoculation as
the mucosa returns to its baseline appearance, and in-
flammatory cells exit the ME cavity.
Despite the extensive inflammation and the significant
morphologic changes that the ME undergoes during
AOM, only approximately 8% of the mouse genome
transcript defines the signature of AOM with NTHi.
This is a remarkably small number of genes when one
considers the transformation of a simple, epithelial layer
into a respiratory epithelium replete with an active in-
flammatory exudate. It can be speculated that, in order
to preserve homeostasis, only a minimum required num-
ber of genes is activated during AOM. Furthermore, it is
noteworthy that perforation of the ME bone and saline
injection without NTHi induced changes in a large num-
ber of transcripts (Figure 2, Additional file 2: Figure S1),
albeit at a typically much lower level of regulation than
with NTHi. Thus, even in the absence of infection, in-
jection trauma and the presence of fluid alone releases
endogenous danger signals that are detectable by recep-
tors in the ME mucosa and its resident leukocytes that
work to repair the punctured mucosa and restore
homeostasis. This suggests the possible existence of a
common danger sensing mechanism in the ME mucosa,
Figure 7 Summary of transcriptional regulation throughout a course of acute otitis media with NTHi. Representation of major events in
the course of an acute episode of otitis media correlated with the major regulatory pathways that are associated with temporal gene clusters.
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control.
We compared our time course data with two datasets
that are available in GEO, generated with different NTHi
strains than the one used in the present study.
MacArthur and co-workers have published a study of
middle and inner ear responses to trans-tympanic heat
killed NTHi versus uninjected controls (GSE49122) [40].
A single time point of 6 h post inoculation was used to
assess early events. In their analysis, 2,355 genes were al-
tered by the killed bacteria. We compared their genes
with our data set from the same time point and found a
79% overlap of their significant genes with our data. We
performed a similar analysis with another, unpublished
dataset (GSE40087) [44] where mice received lysed
NTHi by trans-tympanic injection and ME mucosae
were harvested at 1 and 7d. We found 7,640 genes to be
altered in their dataset by 2-way ANOVA and 63% over-
lap of their regulated genes with our dataset at the same
post-inoculation times. Interestingly, saline injection
through the tympanic membrane alone altered the ex-
pression of many genes, again indicating the importance
of a sham injection control. Lastly, we compiled a list of
genes that have been associated with OM in humans ei-
ther through GWAS or candidate gene studies. We used
GSEA to test whether any of these genes were enriched
in our dataset at any time points. These OM-associated
genes are significantly enriched in NTHi-inoculated
mice at 3, 6, 24 and 48 h but not at later times (FDR <
0.05) (Additional file 6: Table S4). As might be expected,
many of the genes are involved in the inflammatory re-
sponse, for example those encoding IL-10, IL-6, IL-1A,IL-1B, CD14, FAS, MyD88, TLR2, TGFβ1, and TNF, but
we also see association with EHD3, HN1, LRRC47,
PALMD, PPP2R2D at early times (3-6 h), ALDH1A2,
AQR, SFTPD, VLL at later times (24-48 h) and others
such as COL4A2, LDLR, MUC5AC, SERPINE1, and
SLFN5 that seem to be independent of time. We take
this to indicate that our mouse model is representative
of human disease and would be useful to test the role of
these genes.
While exposure of the ME to bacteria initiates an ex-
pected pro-inflammatory response, the microarray data
reveal how the ME controls and modulates this re-
sponse. In addition to the rise of pro-inflammatory cyto-
kines and their receptors early during AOM, a similarly
rapid rise of anti-inflammatory interleukins such as IL-1
receptor antagonist and IL-10 is noted soon after saline
or NTHi injection (Figure 6). In addition, interleukin re-
ceptors involved in inhibiting inflammatory responses,
such as IL-1 type 2 receptor [45], are also significantly
up-regulated with NTHi inoculation (data not shown).
Finally, other negative regulators of pro-inflammatory
intracellular signaling cascades, including those activated
by TLRs and cytokines, are significantly up-regulated al-
most immediately after NTHi inoculation, highlighting
how the negative regulation of inflammatory processes
occurs simultaneously to pro-inflammatory processes in-
volved in host defense.
Dysregulation of the inflammatory response has been
extensively studied in the pathogenesis of various im-
mune or inflammatory disorders, such as juvenile onset
systemic rheumatoid arthritis [46] and chronic auto-
inflammatory syndromes [47]. Thus an over-exuberant
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current OM in some children. However, it is equally
possible that children who suffer from chronic ME dis-
ease have a blunted natural anti-inflammatory response
contributing to their disease process.
There are a number of histological correlates that ap-
pear to validate our array data. The waves of gene ex-
pression patterns identified by DNA microarray analysis
are corroborated by the histological findings noted after
NTHi inoculation, with neutrophil-specific markers de-
tected with the influx of neutrophils histologically into
the ME, followed by macrophage-specific markers corre-
lated with the influx of macrophages. qPCR and West-
ern blot analyses of selected cytokines such as IL-6, IL-1
beta, TNF-alpha, and IL-10 in a murine model of AOM
with NTHi in a C56BL/6 background mouse e.g. [48]
exhibit similar kinetics and degrees of up-regulation to
those observed in this DNA microarray data set, provid-
ing validation of the array results. However, it should be
noted that the use of DNA microarrays harbors limita-
tions for mechanistic explanations of disease processes
as they only measure mRNA expression and fail to as-
sess translation or post-translational processing of pro-
tein products, which have critical roles in determining
the function of proteins. Indeed, we have recently dem-
onstrated the importance of post-translational process-
ing of IL-1beta by the inflammasome in OM [40].
Despite the limitations of microarrays, our array data
are largely consistent with histological data [49], qPCR
data [50], Western blot [51] and immunohistochemical
data [52] from other animal models of NTHi-induced
OM. This supports DNA microarrays or other broad
gene expression assays such as NextGen sequencing, as
methods for the discovery of large numbers of relevant
genes throughout the course of ME disease. This appli-
cation is particularly important in the in vivo study of
AOM, as in vivo experiments in mouse models are es-
pecially labor intensive due to the small amount of re-
coverable ME mucosal tissue, making the piecewise
assessment of individual genes difficult and expensive.
The transcripts up-regulated 7d after NTHi inocula-
tion can be viewed as late resolution genes and/or
“memory” genes that could prepare the ME for subse-
quent re-infection. In the latter category, serum amy-
loids are multifunctional proteins that have bacteriocidal
properties [53] and serve as opsins for gram-negative
bacteria [54]. The persistent up-regulation of genes re-
lated to cognate immunity suggests that the ME retains
adaptive immune function after OM is resolved. This is
consistent with reports that re-infection of animals with
the same bacterial strain typically does not result in OM
[55]. In contrast, the ME does not appear to retain in-
nate immune “memory”. This may help to explain why
the ME is so frequently subject to repeated infection,often by different strains of the same bacterium [56].
Orosomucoids are proteoglycans of uncertain function
that are thought to serve as negative immune modula-
tors involved in the resolution of inflammation [57] and
may have anti-angiogenic properties [58]. Interestingly,
native orosomucoids inhibit phagocytosis and killing of
bacteria by PMNs and monocytes [59] but become acti-
vated by S-nitrosylation during infection to strongly in-
hibit bacterial growth and survival [60]. They may thus
be involved in the bacteriocidal phase and the final reso-
lution of OM.
OM in the mouse shares many of the clinical features
of human ME disease caused by the same organism e.g.
[11,12,21]. Obviously, generalization of animal studies to
humans must be performed with caution, as there are a
number of differences in the immune and inflammatory
systems of mice and humans. Therefore the results of
the present study must be considered with this in mind.
However, it can be hoped that, because we surveyed the
entire course of AOM, our data may reduce the need for
animal experiments to study the expression of individual
not found to be regulated, unless other evidence sug-
gests their importance.Conclusion
In conclusion, transcriptome analysis serves as an explora-
tory step that identifies key genes and gene networks that
contribute to NTHi-induced OM. In particular, the signifi-
cant up-regulation of negative regulators of inflammatory
responses early after NTHi inoculation, ranging from anti-
inflammatory cytokines to intracellular proteins, highlights
the potential regulatory mechanisms involved in the regu-
lation of homeostasis in the ME cavity. Clearly, the ME is
maintained in its normal state by a balance of pro- and
anti-inflammatory signaling, as has been noted at other
body sites e.g. [61]. It can be speculated that dysregulation
of this balance in the ME may lead to processes such as
chronic or recurrent OM in susceptible patients.
Because this method probes the responses of all genes
without bias, the knowledge obtained from gene array
studies may be most useful for the development of new
hypotheses regarding the pathophysiology of OM, and
regarding the process of OM recovery. The information
derived from testing these hypotheses may ultimately af-
ford us the possibility of developing novel treatment
approaches.Availability of supporting data
Upon acceptance for publication, the complete raw data-
set from this study will be deposited in the Gene Expres-
sion Omnibus database and appropriately referenced in
the paper to assure open access.
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Additional file 1: Table S1. Expression profiling data of NTHi
inoculated MEs. A list of 3657 genes found to be significantly
regulated by NTHi when compared to ME saline injection using at
least two methods of analysis. The table gives the probe set ID, the
gene symbol, the fold change relative to untreated mice, the direction of
regulation, the mean raw signal values, the RMA-corrected signals, the
Entrez gene ID, the description, and the chromosomal location of
genes altered during the infection.
Additional file 2: Figure S1. A. Additional principal component
analysis and down-regulated clusters. Principal component analysis
of sample variation including the third principal component
(treatment). Colors of symbols indicate different times and
shapes of symbols indicate different treatments. Clusters of
transcripts down-regulated at 3–6 hours (B, Cluster E), 24 hours (C, Cluster F)
and 3–48 hours (D, Cluster G) after inoculation.
Additional file 3: Table S2. Enrichment analysis for gene expression
clusters. For each gene cluster (genes up at 3-6 h, up at 24 h, up at
3–6 and 48–72, up at 48–72, down at 3-6 h, down at 24 h, or down
at 3-48 h), worksheets report the most enriched canonical pathway
maps, process networks, GO processes, transcription factor connectivity,
transcription factor networks, and pathways linking to transcription
factor networks. For the pathways and processes, tables in worksheets
list the total number of objects, the number of objects in the active data,
the p-value and the FDR corrected p-value for the enrichment, and the
network objects gene symbols involved. For the transcription factor connectivity,
the table lists the actual number of connections, the expected number
of connections, the ratio of actual to expected connections, the p-value
and the z-score for the enrichment. For the network tables, tables show
total number of nodes in the network, the number of seed nodes in
active data (gene cluster), the number of pathways intersecting the
network, the p-value and the z- and g-scores for enrichment.
Additional file 4: Table S3. GSEA analysis of immunologic
signatures at each post-inoculation time point. Worksheets contain
the immunological signatures, the epithelial genesets, and KEGG
pathways enriched at each time point following NTHi inoculation.
Tables list the size of the class, the enrichment score, the normalized
enrichment score, the nominal p-value, the FDR corrected p-value (q-value),
and the Bonferroni family-wise error rate corrected p-value. The top 20
signatures are presented for each time point.
Additional file 5: Figure S2. A. An interactome analysis of PU.1-
connected genes up-regulated at 24 hours after NTHi inoculation.
Genes indicated in red are significantly up-regulated. The interactome of
PU.1 had the most regulated genes of any transcription factor at this
time. B. Gene expression of selected genes. Expression profiles of selected
cytokine, TLR and NLR gene sets.
Additional file 6: Table S4. OM-associated genes enriched in NTHi-
inoculated MEs by GSEA. Worksheet lists the OM-associated genes that
are significantly enriched for each time point.Abbreviations
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